Establishment of a new distribution network through the Pharmaceutical Distribution Study Group with ヤマト運輸
First written in FY2019-Q3. 4 of 8 entries say "Restated". Latest entry: FY2022-Q3.
No other company in this theme has enough history to compare yet.
- FY2022-Q3RestatedAnnual report
「In August 2021, as the first phase of establishing a joint delivery scheme for healthcare products with ヤマト運輸株式会社 (headquartered in Chuo-ku, Tokyo), アルフレッサ developed and introduced systems that use big data and AI to forecast delivery volumes and optimize vehicle dispatching.」
The company continues to describe its efforts to develop and introduce delivery volume forecasting and optimal vehicle dispatching systems as the first phase of the joint delivery scheme with ヤマト運輸. - FY2022-Q2AdvancedAnnual report
「In August 2021, as the first phase of establishing a joint delivery scheme for healthcare products with ヤマト運輸株式会社 (headquartered in Chuo-ku, Tokyo), アルフレッサ developed and introduced a system that uses big data and AI to forecast delivery volumes and a system for optimal vehicle dispatching.」
The joint delivery scheme with ヤマト運輸 progressed to the concrete outcome of developing and introducing systems for forecasting delivery volumes and optimizing vehicle dispatching. - FY2021-Q3RestatedAnnual report
「As part of its efforts to enhance, improve efficiency and standardize group logistics, アルフレッサ entered into a business partnership agreement in July 2020 with ヤマトロジスティクス株式会社 (headquartered in Chuo-ku, Tokyo), a consolidated subsidiary of YAMATO HOLDINGS CO.,LTD. (headquartered in Chuo-ku, Tokyo), to establish a joint delivery scheme for healthcare products, including prescription pharmaceuticals, over-the-counter pharmaceuticals, medical devices, medical supplies and diagnostic reagents.」
The company continues to advance its business partnership with ヤマトロジスティクス to establish a joint delivery scheme for healthcare products. - FY2021-Q2AdvancedAnnual report
「In July 2020, consolidated subsidiary アルフレッサ株式会社 entered into a business partnership agreement with ヤマトロジスティクス株式会社, a consolidated subsidiary of YAMATO HOLDINGS CO.,LTD., to establish a joint delivery scheme for healthcare products, including prescription pharmaceuticals, over-the-counter pharmaceuticals, medical devices, medical supplies and diagnostic reagents. Through this initiative, the companies aim to improve delivery efficiency and enhance delivery capacity for healthcare products.」
The examination of a distribution network with the ヤマト運輸 Group progressed to a business partnership agreement with ヤマトロジスティクス for a joint delivery scheme for healthcare products. - FY2020-Q3RestatedAnnual report
「In September 2019, アルフレッサ jointly developed a home healthcare support service for dispensing pharmacies with ヤマト運輸株式会社 (headquartered in Chuo-ku, Tokyo).」
The company continues to describe the joint development of a home healthcare support service for dispensing pharmacies related to the Pharmaceutical Distribution Study Group with ヤマト運輸, following the previous quarter. - FY2020-Q2AdvancedAnnual report
「In September of this year, アルフレッサ jointly developed a “home healthcare support service for dispensing pharmacies” with YAMATO TRANSPORT CO., LTD. (head office: Chuo-ku, Tokyo).」
The study through the Pharmaceutical Distribution Study Group with ヤマト運輸 progressed to the concrete outcome of jointly developing a home healthcare support service for dispensing pharmacies. - FY2019RestatedAnnual report
「アルフレッサ established the Pharmaceutical Distribution Study Group with ヤマト運輸株式会社 to jointly examine responses to the future healthcare delivery system and social issues such as labor shortages.」
The company continues to describe its examination of a new distribution network through the Pharmaceutical Distribution Study Group with ヤマト運輸. - FY2019-Q3First statedAnnual report
「アルフレッサ and ヤマト運輸株式会社 (headquartered in Chuo-ku, Tokyo, hereinafter "ヤマト運輸") established the Pharmaceutical Distribution Study Group to jointly examine responses to the future healthcare delivery system and social issues such as labor shortages. The joint research aims to rapidly establish a new, safe, secure and reliable distribution network by bringing together アルフレッサ's pharmaceutical distribution network and ヤマト運輸's TA-Q-BIN delivery network, while fully leveraging the management resources and expertise of both companies.」
The companies stated that they aim to establish a new pharmaceutical distribution network by setting up a joint study group with ヤマト運輸 and utilizing both companies' logistics networks, management resources and expertise.